We are at the forefront of developing new treatments and therapies to stop, prevent and reverse liver disease

A shelf of beakers, chemicals and other research equipment

With a patient-centered approach, the Stravitz-Sanyal Institute will transform lives through translational science. Our team of highly specialized physician-scientists conducts cutting-edge investigations through bench research and clinical trials across a broad spectrum of diseases and conditions related to the liver.

Explore our researchers’ publications in the following areas:

As the institute grows, our next step is to apply gene manipulation therapy, a modern medical breakthrough, to bedside treatment for the liver without invasive surgery or medication. This advancement will have immediate benefits to patients here in the Richmond area and impact how we understand and treat the liver worldwide.

Featured Publications

Non-invasive biomarkers of nonalcoholic steatohepatitis: The FNIH NIMBLE project

Diagnosing early-stage NASH is difficult, invasive and expensive. In this letter to the editor of Nature Medicine, Arun Sanyal, M.D., and colleagues describe how the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium plans to develop “reliable non-invasive tools for the diagnosis, risk stratification and monitoring of the course of NAFLD.”

Support our research

Private donations empower top researchers to explore creative solutions. Sign our love letter to the liver by contributing to the Stravitz-Sanyal Institute.

Make a difference now